Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial

The safety and efficacy of spironolactone is uncertain in end-stage renal disease. We randomized 129 maintenance hemodialysis patients to placebo (n=51) or spironolactone 12.5 mg (n=27), 25 mg (n=26), or 50 mg (n=25) daily for 36 weeks in a double-blind, placebo-controlled, multiple dosage trial to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2019-04, Vol.95 (4), p.973-982
Hauptverfasser: Charytan, David M., Himmelfarb, Jonathan, Ikizler, T. Alp, Raj, Dominic S., Hsu, Jesse Y., Landis, J. Richard, Anderson, Amanda H., Hung, Adriana M., Mehrotra, Rajnish, Sharma, Shailendra, Weiner, Daniel E., Williams, Mark, DiCarli, Marcelo, Skali, Hicham, Kimmel, Paul L., Kliger, Alan S., Dember, Laura M., Kliger, Alan, Robinson, Emily, Aurien-Blajeni, Ezra, Cinelli, Maria Angeles, Nizam, Tayyaba, Rim, Sookyung, Seok, Paul, Smith, Caroline, Rollins, Jasmine, Raj, Dominic, Regunathan-Shenk, Renu, Ramezani, Ali, Andrews, Sarah, Dumadag, Michelle, Franco, Christina, Wing, Maria, Anderson, Lisa, Linke, Lori, Manahan, Linda, Hung, Adriana, Cavanaugh, Kerri, Booker, Cindy, Brannon, Brigitte, Clagett, Adrienne, Ellis, Charles, Dember, Laura, Anderson, Amanda, Hsu, Jesse, Cifelli, Denise, Ballard, Shawn, Durborow, Marie, Howard, Tamara, Kuzla, Natalie, Nessel, Lisa, Tierney, Ann, Solomon, Scott, Rad, Aria, Di Carli, Marcelo, Gaber, Masha, Foster, Courtney, Kimmel, Paul, Kusek, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!